Showing results (61-70 of 371) with videos related to

Sort By:
Pageof 38
Brain Research|September 18, 1992
Non-photic phase shifting of the circadian activity rhythm of Syrian hamsters: the relative potency of arousal and melatoninM H Hastings, S M Mead, R R Vindlacheruvu, et al.
Journal of Neuroscience Research|March 25, 1998
Prenatal hippocampal granule cells in primary cell culture form mossy fiber boutons at pyramidal cell dendritesG Grosse, R Tapp, M Wartenberg, et al.
International Journal of Food Microbiology|February 8, 2024
Status quo: Levels of Campylobacter spp. and hygiene indicators in German slaughterhouses for broiler and turkeyA Beterams, C Püning, B Wyink, et al.
Schmerz (Berlin, Germany)|September 17, 2009
[Evaluation of a multimodal pain therapy at the University Pain Centre Dresden]A Schütze, U Kaiser, U Ettrich, et al.
Anticancer Research|December 29, 2000
Tumour microdissemination and survival in metastatic melanomaA J Schrader, M Probst-Kepper, J Grosse, et al.
British Journal of Cancer|March 5, 2002
Interferon-alpha resistance in renal carcinoma cells is associated with defective induction of signal transducer and activator of transcription 1 which can be restored by a supernatant of phorbol 12-myristate 13-acetate stimulated peripheral blood mononuclear cellsA Brinckmann, S Axer, D Jakschies, et al.
Journal of Neuroscience Research|November 1, 2006
Differential distribution of voltage-gated potassium channels Kv 1.1-Kv1.6 in the rat retina during developmentM Höltje, I Brunk, J Grosse, et al.
Melanoma Research|September 14, 2000
Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cellsA J Schrader, M Probst-Kepper, J Grosse, et al.
Ciba Foundation Symposium|January 1, 1995
Immediate-early genes and the neural bases of photic and non-photic entrainmentM H Hastings, F J Ebling, J Grosse, et al.
Molecular Biotherapy|December 1, 1992
Pretreatment natural killer antigen density correlates to clinical response in tumor patients receiving long-term subcutaneous recombinant interleukin-2 and recombinant interferon-alphaS Duensing, M Hadam, A Körfer, et al.
Pageof 38